UAE becomes second country to approve gene therapy Itvisma for spinal muscular atrophy

The UAE has become the second country worldwide to approve Itvisma, a groundbreaking gene therapy for spinal muscular atrophy ...
The Times of Israel on MSN

In surprising breakthrough, scientists in Israel find cancer may help heal the failing heart

A study by researchers at the Technion finds that injecting cancerous serum in mice decreased cardiac fibrosis, paving the ...

Oxana Ali Announces the Safety Based Development Model

Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...
ZAWYA

Emirates Drug Establishment approves gene replacement therapy for new age group in spinal muscular atrophy patients

Dubai, UAE: The Emirates Drug Establishment (EDE) has announced the approval of Itvisma™ (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular ...
Rediff.com

This Blood Test Can Predict Heart Disease Risk

Scientists have developed a simple blood test that can predict which heart disease patients face the greatest risk of ...
Emirates News Agency on MSN

UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...
Edex Live on MSN

UAE approves gene replacement therapy for wider SMA age group

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...
TheHealthSite

Why Vitamin D Supplements May Not Work If Your Kidneys Aren’t Healthy, Doctors Explain

Doctors explain why vitamin D supplements may not work properly if your kidneys are unhealthy, and how kidney function ...
Arabian Business

UAE expands access to gene therapy for spinal muscular atrophy patients

Regulator approves Itvisma for adults and children aged two and above, positioning the UAE among the first countries globally to authorise the treatment for a wider age group ...
MedPage Today on MSN

FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the ...

Millions Drink it Daily, But at what Cost? Sri Ramakrishna Hospital''s Orthopedic Specialists Explain the Link Between Tea, Coffee and Musculoskeletal Pain

Orthopedic Experts at Sri Ramakrishna Hospital also highlight the behavioral aspect linked to tea and coffee consumption. Many people drink tea or coffee after meals while sitting for long ...